Clinical Trials Browser

Phase 1/2 × OTHER_GOV × Nivolumab × Clear all

NCT03685890 2024-04-25

NivoILP

Phase 1/2 Recruiting

Melanoma

NCT02999295 2019-08-21

A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer

Phase 1/2 Completed

Gastrointestinal

Neoplasms, Stomach Neoplasms